Published: October 1st 2024 | Updated: October 3rd 2024
AHA Statement Reviews Benefits, Risks of Alternative Therapies for Heart Failure
Published: September 27th 2024 | Updated: October 3rd 2024
FDA Approves Cobenfy, Previously KarXT, for Treatment of Schizophrenia
Published: September 26th 2024 | Updated: October 3rd 2024
PrEP Prescribing Patterns Reveal Disparities in HIV Prevention Across Settings
Published: September 26th 2024 | Updated: October 3rd 2024
Case Study: Pharmacist Management of Inappropriate Prednisone Dosing Triggered By Asthma
Published: September 27th 2024 | Updated: October 3rd 2024
Teclistamab Demonstrates Continued Deep, Durable Responses in Long-Term Follow-Up From MajesTEC-1 Trial
Published: September 27th 2024 | Updated: October 3rd 2024
CEPHEUS Study Results Show Efficacy of Daratumumab-Based Quadruplet, Triplet Therapeutic Approaches